Eriko Narusawa, Sasagu Kurozumi, Ayaka Katayama, Yukio Koibuchi, Akira Ogawa, Daisuke Takata, Shoko Tokuda, Sayaka Obayashi, Tetsunari Oyama, Jun Horiguchi, et al. Utility of human epidermal growth factor 2 heterogeneity as a prognostic factor in triple-negative breast cancer. Medical molecular morphology. 2024
Ayaka Katayama, Yuki Aoki, Yukako Watanabe, Jun Horiguchi, Emad A. Rakha, Tetsunari Oyama. Current status and prospects of artificial intelligence in breast cancer pathology: convolutional neural networks to prospective Vision Transformers. International Journal of Clinical Oncology. 2024
Sasagu Kurozumi, Naohiko Seki, Eriko Narusawa, Chikako Honda, Shoko Tokuda, Yuko Nakazawa, Takehiko Yokobori, Ayaka Katayama, Nigel P Mongan, Emad A Rakha, et al. Identification of MicroRNAs Associated with Histological Grade in Early-Stage Invasive Breast Cancer. International journal of molecular sciences. 2023. 25. 1
Nobuhiro Nakazawa, Makoto Sohda, Ayaka Katayama, Munenori Ide, Yuki Shimoda, Kohei Tateno, Takayoshi Watanabe, Akihiko Sano, Makoto Sakai, Takehiko Yokobori, et al. Infiltration of Gastric Cancer Stroma by Tumor-Infiltrating Lymphocytes Correlates with mTOR Signaling. Oncology. 2023. 101. 8. 520-526
Predictors of pathologicalcomplete response toneoadjuvant treatment andchanges to post- neoadjuvant HER2 status inHER2-positive invasivebreast cancer
(Edinburgh breast cancer special virtual symposium 2021, Edinburgh, Scotland, UK 2021)